← 產業報告目錄
Adipose-derived Stem Cell Market Size, Share & Trends Analysis Report By Cell Type, By Product Type, By Disease Indication, By Application (Therapeutic, Research, Others), By Region, And By Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-16頁數 180報告編號 INSIGHTACE-8dd2e1dd62
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The Adipose-derived Stem Cell Market is positioned for steady expansion, with a projected CAGR of 10.0% from 2025 to 2034.
At its core, Adipose-derived Stem Cell pertains to called multipotent cells, and they play several intercellular roles in the renewal and regeneration of other tissues and cell types in the body. Stakeholders across the healthcare landscape are expandingly turning to these solutions to meet contemporary demands.
Several factors contribute to this trajectory, including heightened appetite for next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region expected to deliver the strongest growth trajectory through the forecast period, driven by demographic shifts and policy support.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Adipose-derived Stem Cell Market Snapshot
Chapter 4. Global Adipose-derived Stem Cell Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Cell Type Estimates & Trend Analysis
5.1. By Cell Type & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Cell Type:
5.2.1. Autologous stem cells
5.2.2. Allogeneic stem cells
Chapter 6. Market Segmentation 2: By Product Type Estimates & Trend Analysis
6.1. By Product Type & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Product Type:
6.2.1. Cell line
6.2.2. Culture Media
6.2.3. Media
6.2.4. Sera
6.2.5. Reagents
Chapter 7. Market Segmentation 3: By Disease Indication Estimates & Trend Analysis
7.1. By Disease Indication & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Disease Indication:
7.2.1. Cancer
7.2.2. Obesity
7.2.3. Wounds and Injuries
7.2.4. Cardiovascular diseases
7.2.5. Musculoskeletal diseases
7.2.6. Others
Chapter 8. Market Segmentation 4: By Application Estimates & Trend Analysis
8.1. By Application & Market Share, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Application:
8.2.1. Therapeutic
8.2.2. Research
8.2.3. Others
Chapter 9. Market Segmentation 5: By End-user Estimates & Trend Analysis
9.1. By End-user & Market Share, 2024 & 2034
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End-user:
9.2.1. Cell banks & Tissue banks
9.2.2. Research laboratories and Academic institutes
9.2.3. Hospitals and Trauma centers
9.2.4. Others
Chapter 10. Adipose-derived Stem Cell Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts By Cell Type, 2021-2034
10.1.2. North America Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts By Product Type, 2021-2034
10.1.3. North America Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts by Disease Indication, 2021-2034
10.1.4. North America Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
10.1.5. North America Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts By End-user, 2021-2034
10.1.6. North America Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
10.2. Europe
10.2.1. Europe Adipose-derived Stem Cell Market revenue (US$ Million) By Cell Type, 2021-2034
10.2.2. Europe Adipose-derived Stem Cell Market revenue (US$ Million) By Product Type, 2021-2034
10.2.3. Europe Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts by Disease Indication, 2021-2034
10.2.4. Europe Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
10.2.5. Europe Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts By End-user, 2021-2034
10.2.6. Europe Adipose-derived Stem Cell Market revenue (US$ Million) by country, 2021-2034
10.3. Asia Pacific
10.3.1. Asia Pacific Adipose-derived Stem Cell Market revenue (US$ Million) By Cell Type, 2021-2034
10.3.2. Asia Pacific Adipose-derived Stem Cell Market revenue (US$ Million) By Product Type, 2021-2034
10.3.3. Asia Pacific Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts by Disease Indication, 2021-2034
10.3.4. Asia Pacific Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
10.3.5. Asia Pacific Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts By End-user, 2021-2034
10.3.6. Asia Pacific Adipose-derived Stem Cell Market revenue (US$ Million) by country, 2021-2034
10.4. Latin America
10.4.1. Latin America Adipose-derived Stem Cell Market revenue (US$ Million) By Cell Type, (US$ Million) 2021-2034
10.4.2. Latin America Adipose-derived Stem Cell Market revenue (US$ Million) By Product Type, (US$ Million) 2021-2034
10.4.3. Latin America Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts by Disease Indication, 2021-2034
10.4.4. Latin America Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
10.4.5. Latin America Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts By End-user, 2021-2034
10.4.6. Latin America Adipose-derived Stem Cell Market revenue (US$ Million) by country, 2021-2034
10.5. Middle East & Africa
10.5.1. Middle East & Africa Adipose-derived Stem Cell Market revenue (US$ Million) By Cell Type, (US$ Million) 2021-2034
10.5.2. Middle East & Africa Adipose-derived Stem Cell Market revenue (US$ Million) By Product Type, (US$ Million) 2021-2034
10.5.3. Middle East & Africa Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts by Disease Indication, 2021-2034
10.5.4. Middle East & Africa Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
10.5.5. Middle East & Africa Adipose-derived Stem Cell Market revenue (US$ Million) estimates and forecasts By End-user, 2021-2034
10.5.6. Middle East & Africa Adipose-derived Stem Cell Market revenue (US$ Million) by country, 2021-2034
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Allocure, Inc.
11.2.2. Celgene Corporation
11.2.3. Pluristem Therapeutics, Inc.
11.2.4. Intrexon, Inc.
11.2.5. Celleris SA
11.2.6. Tissue Genesis, Inc.
11.2.7. Mesoblast Ltd.
11.2.8. Cytori Therapeutics
11.2.9. Antria, Inc.
11.2.10. ThermoFisher Scientific,
11.2.11. American CrysoStem
11.2.12. Merck KGaA
11.2.13. Others
11.2.14. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們